学术探索
学术期刊
新闻热点
数据分析
智能评审

Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks

被引：52
作者：
Gadde, Kishore M.
Allison, David B.
机构：
[1] Duke Univ, Med Ctr, Obes Clin Trials Program, Durham, NC 27710 USA
[2] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Clin Nutr Res Ctr, Birmingham, AL 35294 USA
来源：
CIRCULATION | 2006年 / 114卷 / 09期
关键词：
obesity; drugs; pharmacology;
D O I：
10.1161/CIRCULATIONAHA.105.596130
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：974 / 984
页数：11
相关论文
共 102 条
[71]   Effect of rimonabant on weight and cardiometabolic risk factors - Reply [J].
Pi-Sunyer, F. Xavier .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (06) :650-651
[72]   A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity [J].
PiSunyer, FX .
CLINICAL THERAPEUTICS, 1996, 18 (06) :1006-1035
[73]  
*ROCH PHARM, 2005, PRESCR INF XEN ORL C
[74]  
ROSENSTOCK J, 2005, ANN M AM DIAB ASS JU
[75]   Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity [J].
Rössner, S ;
Sjöström, L ;
Noack, R ;
Meinders, AE ;
Noseda, G .
OBESITY RESEARCH, 2000, 8 (01) :49-61
[76]  
Sanofi Aventis, 2006, SAN AV REC FDA APPR
[77]  
SCHEEN A, 2005, 65 SCI SESS AM DIAB
[78]   The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats [J].
Serra, S ;
Carai, MAM ;
Brunetti, G ;
Gomez, R ;
Melis, S ;
Vacca, G ;
Colombo, G ;
Gessa, GL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 430 (2-3) :369-371
[79]  
Simiand J, 1998, BEHAV PHARMACOL, V9, P179
[80]   A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine [J].
Singh, ME ;
Verty, ANA ;
McGregor, IS ;
Mallet, PE .
BRAIN RESEARCH, 2004, 1026 (02) :244-253
234567891011